Over 24,000 people have signed up as volunteers that will be infected with COVID-19 to help in the development of a vaccine.
Based on the website of the 1 Day Sooner campaign, 24,292 individuals from 102 countries registered to participate in human challenge trials (HCTs).
The said campaign initiated by a group of researchers and professionals in the United States and the United Kingdom appeals to people ages 20 to 45 years old without underlying health conditions to submit themselves for the speedy research for the COVID-19 vaccine.
“Human challenge trials deliberately expose participants to infection, in order to study diseases and test vaccines or treatments,” the 1 Day Sooner team explained.
“Researchers are exploring whether human challenge trials could speed up the development of a vaccine for COVID-19, saving thousands or even millions of lives,” they added.
According to the 1 Day Sooner team, this methodology is effective in combating other diseases like smallpox, influenza, cholera, malaria, typhoid fever, dengue and zika.
The group also related their hypothesis that if one-sixth of the world’s population is infected by the virus per year and a vaccine prevents the death of 0.2% of the said population, expediting vaccine development might lead to more than half a million lives saved.
It furthered that hastening the vaccine development by one day saves 7,120 lives, 55,000 lives for one week, 220,000 lives for one month, and 660,000 lives for three months.
Based on data presented by Johns Hopkins as of May 21, 2020, there are 5,022,064 confirmed COVID-19 cases worldwide with 328,639 deaths.